Sign Up to like & get
recommendations!
0
Published in 2017 at "Contemporary clinical trials"
DOI: 10.1016/j.cct.2016.12.007
Abstract: Population-based carrier screening is limited to well-studied or high-impact genetic conditions for which the benefits may outweigh the associated harms and costs. As the cost of genome sequencing declines and availability increases, the balance of…
read more here.
Keywords:
genomic carrier;
carrier screening;
design randomized;
randomized controlled ... See more keywords